Pancreatic amylase 18000 units and pancreatic lipase 25000 units and pancreatic protease 1000 units gastro-resistant oral capsule
RxNorm 2642125
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2642125 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Pancreatic amylase 18000 units and pancreatic lipase 25000 units and pancreatic protease 1000 units gastro-resistant oral capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Pancreatic amylase 18000 units and pancreatic lipase 25000 units and pancreatic protease 1000 units gastro-resistant oral capsule
(Atom ID: 12821324)
FN